HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 10, October 2018 – Next-generation biosensors - Transforming the delivery of healthcare       » China tops world in alcohol-related deaths       » First China-developed drug for colorectal cancer approved in China       » World's first shrimp genome may reveal why females are superior       » Tetris-like program could speed breast cancer detection       » Wearable patch to monitor blood pressure inside body      
COLUMNS
Clinical program for oral immunotherapy for food allergies
Oral immunotherapy for food allergies can bring significant benefits to children with food allergies. It carries risks and has a significant cost. This treatment requires significant commitment from the children and their caregivers, for it to be performed safely and effectively.
by Dr Soh Jian Yi

Food allergies are common and appear to be on the rise. These allergies can be severe, and the reactions can be life-threatening. Conventional management is to ask the patient to avoid the food allergen to the best of their ability. However, accidental exposures are common. Deaths occur every year due to inadvertent exposure to a food the person is allergic to. The ongoing psychological burden on the allergic child, as well as the child’s parents – always having to be vigilant, when eating or buying food to eat every day – is considerable. Combined with greater awareness of the problems food allergies cause, there has been increased interest in the prevention and treatment of food allergies in recent years.

Oral immunotherapy for food allergies has been researched for over a decade. This treatment involves giving the allergic patient, tiny amounts of the food the patient is allergic to, to raise the “threshold of reactivity” (ToR) (the minimum amount of allergen that specific patient has to be exposed to, to develop a reaction. Exposure to amounts less than that do not cause reactions) that patient has to the food. For example, if a peanut-allergic child has the ToR raised to 20 roast peanuts’ worth, that child can eat any peanut-containing food up to 19 roast peanuts’ equivalent, without any problems. This makes it vastly safer for the child to eat (since it would be difficult to accidentally eat 20 or more roast peanuts), as well as alleviates the psychological burden on the child as well as the parents. Another benefit is to give the child more dietary choices.

The difficulty in offering this treatment lies in doing so consistently, precisely, and in amounts tiny enough that the treatment does not exceed the ToR for that patient. Many of the “high-risk” foods, such as peanut and tree nuts, tend to cause severe reactions. Patients with allergies to these high-risk foods also tend to have a very low ToR, which is why even contamination of the cooking utensil with the food allergen can result in severe allergic reactions for them.

For the above reasons, researchers have often stated that immunotherapy is not yet ready for routine clinical practice. They are right, in the sense that the degree of caution, foresight and communication between healthcare team, patient and patient’s caregivers is far greater than what would be routinely possible in many outpatient clinical practice settings.

Having said that, oral immunotherapy for food allergies in children, has been ongoing at the National University Hospital of Singapore since the year 2015. This is offered as a clinical service. Given the commitment required and stakes involved, a detailed discussion with the child and his/her caregivers is undertaken. This discussion involves costs, risks, precautions, benefits and flexible scheduling – important in our fast-paced society, since children can fall sick at any time, there are also school and overseas trips to factor in, and taking leave to bring the child to the hospital for treatment can be difficult for working parents.

The child then undergoes the treatment, which involves daily dosing at home under supervision of the adult caregiver; and visits to the children’s Day Therapy ward once or twice a month, where they will eat an increased dose of the allergen under medical supervision.

Communication with the healthcare team is available through multiple channels; the families can contact the head of the programme at any time, any day, should there be urgent or emergent issues. The need to take ownership of any concerns or upcoming scheduling plans the child or family has, and to alert the healthcare team of those concerns, is emphasized so as to ensure everything runs optimally for all involved. Likewise, the family is aware that the healthcare team takes ownership of their expertise and ability to assist, and thus will do their best to help the family – but can only do so if the family works closely with the medical team.

Near the end of the treatment, the child will be able to decide whether he/she likes the food. This is important because the treatment is not a “cure”. At the end of the treatment, the child still needs to take the food allergen regularly to maintain the higher ToR. Some children dislike the food allergen; if so, the final aim of the treatment may be to tolerate accidental ingestion, rather than meal-size amounts. This is because, if a child dislikes that food, it would not be sustainable to ask them to eat meal-size portions of that food regularly in the long term. Suppose the child undergoes peanut immunotherapy, and discovers they do not enjoy the taste of peanuts. Given the benefits of maintaining the higher ToR, it is not advisable to stop taking the peanut allergen completely, which would mean abandoning the benefits gained. Instead, to have them eat one to two peanuts regularly and for the long-term once the treatment is completed, is a small price to pay for the benefits of being much safer from accidental exposure, and the relief from the psychological burden on the child and parents.

Happily, upon completing the treatment, many children do enjoy eating the foods they were previously unable to take. Their dietary choices expand tremendously, and they are happier. Children who were unable to enjoy birthday parties fully and could not take many desserts due to egg and milk allergies, were able to do so. Some have their own birthday cakes where previously they never had one before – a joyous moment for the child and the parents.

Currently, the program is available for children with allergies to peanut, egg, milk, wheat, and tree nuts.

Dr Soh Jian Yi is a pediatrician and allergy specialist for the National University Hospital of Singapore and an assistant professor at the Yong Loo Lin School of Medicine. His research interest lies in the fields of allergy and immunology; he has a particular focus on food allergy and desensitisation. Dr. Soh runs a clinical immunotherapy program for the treatment of food allergies.

Click here for the complete issue.

NEWS CRUNCH  
news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
news Vitafoods Asia expands by 40 per cent in 2018
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Cancer - Therapies and strategies for better patient outcomes
July:
Water management - Technologies for biotech and pharmaceutical industries
August:
Regenerative technology - Meat of the future
September:
Doctor Robot - The digital healthcare revolution
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy